Labi Exames
- Company typePrivate
- Founded2017
- HeadquartersSão Paulo, Brazil
- Headcount51–100
- GTM typeB2C
- OfferingServices
Labi Exames firmographics
Firmographics- Name
- Labi Exames
- Website
- https://labiexames.com.br
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Labi Exames industry classification
Industry- Product category
- Diagnostic Laboratory Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Central Laboratory Services (Core Lab Operations) (HLAGAEAA)
- akta.pro secondary industry
- Clinical Research & Trial Central Laboratories (HLAFAMAL)
Keywords
Where Labi Exames is headquartered
LocationHeadquarters
- HQ city
- São Paulo
- HQ country
- Brazil
- HQ region
- Latin America
Offices1 record
Markets served
Labi Exames business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Laboratory Test Services: One-time transaction-based revenue from individual laboratory tests purchased by consumers directly through website, app, or at physical units. Also accepts health insurance plans for covered tests.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | At-home collection service at R$ 250+ |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels3 records
Labi Exames product offering
Product offeringCore offering
Labi Exames (operating as Labi Saúde) is a Brazilian diagnostic laboratory company that provides clinical laboratory tests directly to consumers without requiring a doctor's prescription. Services can be purchased through the website, mobile app, or at physical collection units located near metro stations. The company also offers at-home blood sample collection for orders starting at R$ 250 and administration of immunobiological medications.
Product overview
Labi Exames (Labi Saúde) is a laboratory testing company offering a unified service platform for clinical diagnostic tests. The core product is laboratory testing services (Exames Laboratoriais), complemented by home collection services (Coleta Domiciliar), infusion services (Infusões) for immunobiological medication administration, and commented medical reports (Laudo Comentado). Tests can be purchased online, via app, or in-person at modern units near metro stations, with results accessible through the website.
Differentiator
Problem solved
Functional benefit
Products and services
- Exames Laboratoriais (Laboratory Tests)
- Coleta Domiciliar (Home Collection)
- Infusões (Infusions)
Companies that use Labi Exames
Customer profileSegments2 records
Ideal customer profiles1 record
Labi Exames technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Labi Exames partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights5 records
Labi Exames competitors and assessment
Company assessmentBroad incumbents
- Dasa: Largest integrated diagnostics company in Brazil, operating a national network of clinical labs and hospital diagnostics. Comparable because it offers the same routine test catalog to consumers and health plans, but at much greater scale and through B2B2C channels.
- Fleury: Major Brazilian clinical laboratory chain with premium positioning and broad health-plan relationships. Comparable because it serves overlapping consumer test needs in São Paulo and other major metros, with an established brand Labi must compete against.
- Sabin Diagnóstico e Saúde: Brazilian diagnostics chain offering clinical lab tests, imaging, and outpatient services across multiple states. Comparable because it sells the same routine exam catalog to consumers, though through a more traditional B2B2C model.
- Delboni Auriemo: São Paulo–based clinical laboratory brand (part of Dasa) operating in Labi's home geography. Comparable because it serves the same urban São Paulo consumer for routine diagnostic tests and competes for the same foot-traffic and prescription-driven demand.
- Hermes Pardini: Brazilian diagnostics network (part of Dasa) covering Minas Gerais and other regions with clinical lab and imaging services. Comparable because it sells overlapping routine lab tests to consumers and corporate clients through its own unit network.
- Diagnósticos da América (Dasa consumer brands): Dasa's consumer-facing brands (e.g., a+ , Delboni, Lavoisier) that increasingly offer digital booking, home collection, and prescription-free tests. Comparable to Labi because incumbents are actively copying Labi's DTC playbook at much greater scale.
Direct peers
- Dr. Consulta: Brazilian digital health platform offering affordable outpatient consultations and lab tests to consumers without health plans. Directly comparable to Labi because of overlapping low-cost, cash-pay, digital-first D2C model targeting underinsured Brazilian consumers.
- Beep Saúde: Brazilian DTC health services startup offering at-home sample collection and lab testing booked via app. Most directly comparable to Labi because both offer prescription-free tests via mobile app with home collection, targeting similar price-sensitive urban consumers.
Emerging players
- Hilab: Brazilian digital diagnostics startup offering connected rapid-testing devices and online lab test ordering. Comparable to Labi because it targets the same prescription-free, app-driven consumer testing niche, though with proprietary point-of-care hardware rather than traditional venipuncture collection units.
- Alliança Saúde: Brazilian diagnostic medicine group with lab and imaging services across multiple states. Comparable because it competes in routine clinical lab testing for Brazilian consumers and health plans, though with a more regional rather than DTC focus.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Labi Exames financial estimates
Financial estimateRevenue estimate
Valuation estimate
Labi Exames leadership team
Management profileNumber of profiles
Profiles2 records
Labi Exames funding detail
Funding detailFunding overview
Funding rounds3 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Labi Exames M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Labi Exames
What does Labi Exames do?
Labi Exames (operating as Labi Saúde) is a Brazilian diagnostic laboratory company that provides clinical laboratory tests directly to consumers without requiring a doctor's prescription. Services can be purchased through the website, mobile app, or at physical collection units located near metro stations. The company also offers at-home blood sample collection for orders starting at R$ 250 and administration of immunobiological medications.
Is Labi Exames a public or private company?
Labi Exames is a private company. It is classified as venture growth investor backed and is currently operating.
When was Labi Exames founded?
Labi Exames was founded in 2017. It employs 51 to 100 people.
Where is Labi Exames based?
Labi Exames is headquartered in São Paulo, Brazil, in the Latin America region.
How does Labi Exames make money?
One revenue line is on record: laboratory Test Services.
Who are Labi Exames's main competitors?
Broad incumbents on record are Dasa, Fleury, Sabin Diagnóstico e Saúde, Delboni Auriemo, Hermes Pardini and Diagnósticos da América (Dasa consumer brands). Direct peers are Dr. Consulta and Beep Saúde. Emerging players are Hilab and Alliança Saúde.
Does Labi Exames have an API?
No public API is recorded for Labi Exames.
What industry is Labi Exames in?
Labi Exames's product category is Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAGAEAA, Central Laboratory Services (Core Lab Operations), with a secondary code of HLAFAMAL, Clinical Research & Trial Central Laboratories. Its NAICS code is 621511 and its SIC code is 8071.